DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Urologic Condition

Urinary Incontinence

MODERATE

The involuntary loss of bladder control, ranging from occasional leakage to complete inability to hold urine. Affects twice as many women as men, especially after pregnancy, childbirth, and menopause. Not a normal part of aging but becomes more common with age.

Global Affected

423.0M

Countries

111

Symptoms

Stress incontinence (leakage with cough/sneeze)
Urge incontinence (sudden strong urge)
Overflow incontinence (dribbling)
Functional incontinence (can't reach toilet)
Mixed incontinence
Nocturnal enuresis (bedwetting)
Frequent urination
Urgency

Treatment Options

Pelvic floor exercises (Kegels)
Bladder training
Antimuscarinic medications
Beta-3 agonists (mirabegron)
Vaginal estrogen cream
Botox bladder injections
Sacral nerve stimulation
Tibial nerve stimulation
Urethral bulking agents
Sling procedures

Risk Factors

1Female gender
2Pregnancy and childbirth
3Menopause
4Aging
5Obesity
6Chronic cough
7Pelvic surgery
8Neurological disorders
9Family history
10Smoking

Diagnostic Methods

  • 1Voiding diary
  • 2Physical examination
  • 3Urinalysis (rule out infection)
  • 4Post-void residual measurement
  • 5Urodynamic testing
  • 6Cystoscopy
  • 7Pad test
  • 8Urine stress test

Prognosis

Highly treatable; 80% improve with conservative measures. Behavioral therapies effective for mild-moderate cases. Medications help urge incontinence. Surgery has high success rates (80-90%) for stress incontinence. Recurrence possible, especially with aging.

Prevention

  • Pelvic floor exercises
  • Maintain healthy weight
  • Treat chronic cough
  • Avoid bladder irritants (caffeine, alcohol)
  • Don't smoke
  • Regular bathroom schedule
  • Proper lifting techniques

Research Status

Pelvic floor muscle training (Kegel exercises) is first-line. Antimuscarinics (oxybutynin, tolterodine) and beta-3 agonists (mirabegron) for urge incontinence. Botox injections for refractory cases. Neuromodulation (sacral nerve stimulation, tibial nerve stimulation). Surgical options: mid-urethral slings, colposuspension, artificial urinary sphincter.

Affected Countries

United StatesUnited KingdomCanadaAustraliaGermanyFranceItalySpainJapanChinaIndiaBrazilRussiaSwedenNetherlandsBelgiumSwitzerlandAustriaDenmarkNorwayFinlandPolandCzech RepublicHungaryRomaniaBulgariaCroatiaSloveniaSlovakiaLTLVEEIrelandPortugalGreeceCYMTLUIcelandNew ZealandSouth KoreaSingaporeTaiwanHong KongMalaysiaThailandVietnamIndonesiaPhilippinesSouth AfricaNigeriaEgyptTurkeyIranSaudi ArabiaUAEQatarKuwaitOmanJordanLebanonSyriaYemenIraqAfghanistanPakistanBangladeshLKNPMMKHLAMNKazakhstanUzbekistanTMKGTJAzerbaijanAMGEUkraineBelarusMDALBAMEMKSerbiaXKMexicoArgentinaChileColombiaPeruVenezuelaEcuadorUYPYBOCRPAGuatemalaHNSVNIBZJMHaitiDominican RepublicCuba

Sources

  • https://www.niddk.nih.gov/health-information/urologic-diseases/bladder-control-urinary-incontinence
  • https://www.cdc.gov/aging/disabilities/bladder.htm
  • https://www.hematology.org/education/patients
  • https://www.ncbi.nlm.nih.gov/books
  • https://rarediseases.org/rare-diseases

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.